Plus: What Ozempic might tell us about the future of Alzheimer's

December 22, 2025 Check out STAT+

Sponsored By

The gift of science never goes out of style. Get 25% off STAT+ today for unlimited access to our biopharma and public health coverage.

FREDERIC J. BROWN/AFP via Getty Images American food safety could be headed for a breakdown Food safety experts say federal cuts this year, including scaled-back FoodNet surveillance, will expose more Americans to foodborne illness. By Sarah Todd NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled NIH researcher raised hopes with study of topical steroid withdrawal. A look at how it unraveled in Part 10 of 'American Science, Shattered' By Eric Boodman STAT+ | A seasoned biotech VC looks to 2026 and sees a wave of IPOs coming Atlas Venture's Bruce Booth believes more drugmakers are ready to access public markets in the coming year. By Allison DeAngelis Molly Ferguson for STAT STAT+ | Opinion: What Ozempic might tell us about the future of Alzheimer's Ozempic has become, like Prozac, a paradigm-shifting drug. What will Alzheimer's iconic drug look like? By Jason Karlawish Study revives debate about unpopular diet for cancer patients The neutropenic diet, in which nearly all food is cooked at high heat to decrease infection risk, was waning in cancer care. A new study could change that. By Angus Chen Opinion: Why Denmark's vaccine schedule works for Denmark — but not for the United States When it comes to vaccines, Denmark and the U.S. have fundamentally different health care systems, disease burdens, and policy priorities. By Jake Scott Christine Kao/STAT STAT+ | 3 key issues to watch at FDA as Makary struggles to stabilize the agency Executive turnover, political interference in scientific pursuits, and deregulation loom large at the FDA in 2026. Learn more in STAT's '3 To Watch.' By Lizzy Lawrence

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser